“…Reported adverse events associated with ILE infusions are sporadic or extrapolated from its use in parenteral nutrition, there is a case report of suspected acute respiratory distress syndrome (ARDS) secondary to the use of ILE for verapamil toxicosis (12). The adverse events reported with ILE infusions include phlebitis, immunosuppression, cardiovascular, lipid-emboli, hemolysis, acute kidney injury, metabolic acidosis, pulmonary complications (acute lung injury, ARDS, hypoxia and ventilation-perfusion mismatch), pancreatitis or fat overload syndrome, hypersensitivity or allergic reactions and vomiting, persistent gross lipemia and suspected corneal lipidosis (2, 7, 9–11, 13–19).…”